SCHEMBL15568298

SCHEMBL15568298

O=C(Nc1ccccc1CCc1nc(Nc2cnn(C3CCNCC3)c2)ncc1Cl)C1CC1

nearest known ligand 0.70

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ FLT4 P35916 18/20 0.70
▸ KDR P35968 12/20 0.70
▸ IGF1R P08069 1/20 0.48
▸ AURKB Q96GD4 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15568521 0.84 FLT4 (0.61) FLT4KDR
SCHEMBL28107724 0.84 FLT4 (0.69) FLT4KDR
SCHEMBL15506704 0.83 FLT4 (1.00) FLT4KDR
SCHEMBL15506861 0.82 FLT4 (1.00) FLT4KDR
SCHEMBL15506726 0.78 FLT4 (1.00) FLT4KDR
SCHEMBL15567622 0.78 FLT4 (0.67) FLT4KDR
SCHEMBL28107473 0.77 ACVRL1 (0.44) FLT4KDR
SCHEMBL15524050 0.75 FLT4 (0.66) FLT4KDR
SCHEMBL15506853 0.74 FLT4 (1.00) FLT4KDR
SCHEMBL15506620 0.74 FLT4 (0.84) FLT4KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2885291-A1 VEGFR3 INHIBITORS Cancer Therapeutics Crc Pty Limited (AU) 2015-06-24 — — EP disclosed
WO-2014026243-A1 VEGFR3 INHIBITORS CANCER THERAPEUTICS CRC PTY LIMITED (AU) 2014-02-20 — — WO disclosed
Send feedback